Big Finish to a Winning Week

Options Reviews 

To close out what has been a very interesting trading week, we will start by going over our winning options plays from yesterday morning’s premarket report. We had signaled some ideas in the RAD and ACN chains that put up quite a nice intraday performance.

The targets to which we are specifically referring were the RAD Weekly $13.50-14.40 Calls and the ACN Weekly $207.50-212.50 Calls. All of the sets in those ranges produced notable moves on the day:

RAD Weekly $13.50-14.50 Calls
$13.50:  .86-3.15 (+266%)
$14: .59-2.69 (+356%)
$14.50: .34-2.11 (+521%)

We’re going to refresh our idea here and roll up to the RAD Weekly $16-16.50 Calls* as well this morning.

*Please do not attempt to trade weekly options on a Friday unless you are an advanced trader with access to disposable funds!
_____

ACN Weekly $207.50-212.50 Calls
$207.50:  4.22-10.50 (+149%)
$210: 3.50-8.23 (+135%)
$212.50 2.02-6.00 (+197%)
____

Fresh Options Ideas:
PRGS 07/17 $40 Calls
SNX 07/17 $115-120 Calls 



Other Updates

We’ve also got a few other stock calls that have exploded toward the end of this week, illustrating the excellence we regularly exhibit in seeking out all types of gain opportunities:

Vaxart, Inc. VXRT
Alerted: 06/25 |  Range: 3.45-12.28 | Gain: 256%
____

AeroVironmentB Inc. AVAV
Alerted: 06/24 |  Range: 1.65-6.30 | Gain: 282%
____

Global Arena Holding Inc. GAHC
Alerted: 06/25 |  Range: .0027-.015 | Gain: 456%


Extended Watchlist:
ALYI, PNAT, EKSO, DLCR, BLIC

OTC Review, Fresh Options Plays

OTC Winners 

As we have been continuously mentioning in recent weeks, while our primary interest is still in quick-strike options trading, we need to follow the money, and the OTC has been producing for us in a big way. Traditional technical trading on the big boards has taken a hit amid the effects brought on by the coronavirus, and doesn’t look to be making a comeback for quite some time.

Here are a few examples of recent penny stocks we’ve tagged that have proven their utility in attaining the fast profits for which we are always on the lookout. 

Artificial Intelligence Technology Solutions Inc. AITX
Alerted: Yesterday (06/24) |  Range: .0299-.095 | Gain: 218%
____

Data443 Risk Mitigation Inc. ATDS
Alerted: 06/17 |  Range: .0095-.0219 | Gain: 131%
____

Ozop Surgical Corp. OZSC 
Alerted: 04/30 |  Range: .0049-.0530 | Gain: 982%


Earnings Related Options Plays: 

RAD Weekly $13.50-14.40 Calls 

DRI 07/17 $70-75 Calls 
ACN Weekly $207.50-212.50 Calls


Extended Watchlist:
VXRT, GAHC, GTEH, GMEV

Tons of Updates, New Ideas

Options Reviews

Our ideas in the Mastercard and Boeing chains from yesterday’s report both played out very nicely for us, producing sizable intraday gain opportunities for ourselves and our readers. Here are the gains that have been made so far.

MA Weekly $272.50-277.50 Calls
$272.50: 6.03-13.00 (+116%)
$275: 4.58-10.75 (+135%)
$277.50: 3.25-8.74 (+169%)

BA Weekly $138-140 Calls
$138: 
2.57-10.39 (+304%)
$139: 2.25-9.68 (+330%)
$140: 1.82-9.13 (+402%)
_____

AMC Entertainment Holdings Inc. AMC – Update

We also got a new high in our AMC 06/19 $4 Calls, an options idea we formulated after our associate trader, Nicholas in VA, called our attention to the stock. These calls have now made a move .55-1.83 in just a couple of sessions, marking a total gain of 233%
_____

Fresh Ideas:
MSFT Weekly $177.50-180 Calls
TSLA $840-860 Calls
SPY 05/04 $291-288 Puts
MCD Weekly $185 Puts



Stock Updates

We also had a couple of stock calls from our extended watchlist produce some solid gain chances for us, which were as follows.

Ozop Surgical Corp. OZSC 
Range: .0133-.0247 – Total Gain: 86%

Transportation and Logistics Systems, Inc. TLSS
Range: .0421-.094  – Total Gain: 123%


Vaxart Inc. VXRT – News Alert

We’ve been tracking VXRT pretty closely in recent weeks, and wanted to include a lonk to the coronavirus news the company put out this morning, which points to the company possible making some headway in the fight to develop a vaccine. It’s sending the stock on a ride in the premarket, and keeping us on high alert.

SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.(>>View Full PR)